Voalte receives $17M in capital infusion

According to a press release, healthcare communication technology company Voalte announced a new capital infusion of $17 million from Ascension Ventures, Cerner-affiliated Cerner Capital, Inc. and Bedford Fudning.

This Series D funding will be used to sustain further growth for Voalte. Voalte has seen a rapidly expanding customer base, with last quarter signing on 44 new sites with Voalte technology.

Trey Lauderdale, Founder and CEO of Voalte is looking forward to watching Voalte expand thanks to the funding.

"I'm excited about the partnership and how it will enable us to continue to push the envelope on advancing healthcare communication," said Lauderdale.

This is not the first time Bedford Funding is backing Voalte. In February 2014, Bedford Funding invested $36 million in Voalte.

To read more about the funding, click here.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars

>